Sulfasalazine

Spezifikationen

599-79-1CAS-Nummer

2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acidIUPAC-Name

C18H14N4O5SChemische Formel

398.4 g/molMolekulargewicht

sulfasalazine; 599-79-1; Salicylazosulfapyridine; Azulfidine; Salazosulfapyridine; Sulphasalazine; Salazopyrin; Benzosulfa; Sulcolon; Asulfidine; Azopyrine; Salazopyridin; Accucol; Azopyrin; Salisulf; Salazopiridazin; Reupirin; Colo-Pleon; Salazosulfapyridin; w-t Sasp oral; Sulfasalazin; Sulfasalazina; Sulfasalazinum; Sulfazalazine; Azulfidine EN-tabs; Sas-500; Azulfidine EN; SASP; Salazosulfapiridina; Salazosulfapyridinum; (E)-2-hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid; 5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid; S.A.S.-500; 5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid; NSC 667219; 4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene; 5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid; 2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid; 5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid; MFCD00057363; NSC 203730; S.A.S. 500; C18H14N4O5S; Sulfasalazopyridine; CHEBI:9334; DTXSID0021256; Benzoic acid, 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]-; 3XC8GUZ6CB; 737754-28-8; NSC-203730; NSC-667219; S.A.S.; Azosulfidin; 2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid; 2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 2-Hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid; 5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid; Benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-; 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID; 2-hydroxy-5-(2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl)benzoic acid; Benzoic acid, 2-hydroxy-5-[2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl]-; NSC203730; NSC667219; s1576; Salicylic acid, 5-((p-(2-pyridylsulfamoyl)phenyl)azo)-; NCGC00090903-01; Salazo-sulfapyridinum; CAS-599-79-1; 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic acid; 2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid; 5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid; (3Z)-6-Oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid; 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid; DTXCID401256; Sulfasalazinum [INN-Latin]; Sulfasalazina [INN-Spanish]; Salicylic acid, 5-[[p-(2-pyridylsulfamoyl)phenyl]azo]-; 2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid; Salazosulfapyridinum [INN-Latin]; Salazosulfapiridina [INN-Spanish]; SI-88; 2-Hydroxy-5-[(1E)-2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl]benzoic acid; Azulfidine (TN); SAS; SMR000059146; Sulphasalazine, N-; CCRIS 4713; HSDB 3395; 13gs; 5-(p-(2-Pyridylsulfamoyl)phenylazo)salicylic acid; SR-05000001721; EINECS 209-974-3; UNII-3XC8GUZ6CB; Sulfasalazine (USP/INN); BRN 0356241; Iwata; Sulfasalazine RS; 2-hydroxy-5-({4-[(2-pyridylamino)sulfonyl]phenyl}diazenyl)benzoic acid; 2-Hydroxy-5-{{4-[(2-pyridinylamino)sulfonyl]phenyl}azo}benzoic acid; Sulfasalazine CRS; Prestwick_848; Sulfasalazine [USAN:USP:INN:BAN]; Spectrum_000998; Sulfasalazine (Standard); Prestwick0_000520; Prestwick1_000520; Prestwick2_000520; Prestwick3_000520; Spectrum2_001216; Spectrum3_001364; Spectrum4_000347; Spectrum5_001443; Sulfasalazine (Azulfidine); SULFASALAZINE [MI]; CHEMBL421; Epitope ID:122672; SULFASALAZINE [INN]; SCHEMBL4514; SCHEMBL4515; Salazosulfapyridine (JP18); SULFASALAZINE [HSDB]; SULFASALAZINE [IARC]; SULFASALAZINE [USAN]; SCHEMBL18490; BSPBio_000479; BSPBio_002888; KBioGR_000753; KBioGR_002314; KBioSS_001478; KBioSS_002316; SULFASALAZINE [VANDF]; 5-22-08-00433 (Beilstein Handbook Reference); MLS000759399; MLS001424109; MLS006011702; BIDD:GT0161; DivK1c_000860; SPECTRUM1500552; SULFASALAZINE [MART.]; SPBio_001032; SPBio_002400; SULFASALAZINE [USP-RS]; SULFASALAZINE [WHO-DD]; SULFASALAZINE [WHO-IP]; BPBio1_000527; CHEMBL100848; CHEMBL242373; GTPL4840; orb1224519; orb1310181; SCHEMBL1079598; SCHEMBL1229516; SCHEMBL10289061; SCHEMBL29861725; SCHEMBL31174674; SCHEMBL31296204; CHEBI:94500; HMS502K22; KBio1_000860; KBio2_001478; KBio2_002314; KBio2_004046; KBio2_004882; KBio2_006614; KBio2_007450; KBio3_002108; KBio3_002794; SALAZOSULFAPYRIDINE [JAN]; cMAP_000018; NCEXYHBECQHGNR-QZQOTICOSA-N; NINDS_000860; OQANPHBRHBJGNZ-BKUYFWCQSA-N; OQANPHBRHBJGNZ-UHFFFAOYSA-N; GLXC-07725; HMS1569H21; HMS1921C05; HMS2051J21; HMS2090P13; HMS2092K07; HMS2096H21; HMS2232H07; HMS3370D16; HMS3393J21; HMS3655G07; HMS3713H21; HMS3871J13; HMS3884E21; HMS5079K16; Pharmakon1600-01500552; SULFASALAZINE [ORANGE BOOK]; ALBB-033361; MSK10667; SULFASALAZINE [EP MONOGRAPH]; Tox21_111037; Tox21_201239; Tox21_300541; BDBM50097125; BDBM50103596; CCG-39145; DL-510; EBC-04435; HY-14655R; NSC757330; s8247; SBB058178; SULFASALAZINE [USP MONOGRAPH]; SULFASALAZINUM [WHO-IP LATIN]; AKOS002311709; AKOS025116975; AKOS026749974; AKOS037515748; Tox21_111037_1; WLN: T6NJ BSWMR DNUNR DQ CVQ; AS27942; CCG-100987; DB00795; HS-0062; NC00237; NSC-757330; IDI1_000860; SMP2_000059; NCGC00016518-01; NCGC00090903-02; NCGC00090903-03; NCGC00090903-04; NCGC00090903-05; NCGC00090903-06; NCGC00090903-07; NCGC00090903-08; NCGC00090903-09; NCGC00090903-11; NCGC00090903-12; NCGC00090903-21; NCGC00186644-01; NCGC00254313-01; NCGC00258791-01; AC-20497; HY-14655; PD087097; SMR004703430; SY052318; SBI-0051526.P003; DB-017797; NS00011872; S0580; ST50767935; SW196979-4; T0907; C07316; D00448; EN300-119546; H10652; AB00052101-04; AB00052101-06; AB00052101_07; AB00052101_08; F358095; F806146; Q420035; SR-05000001721-1; SR-05000001721-2; SR-05000001721-3; Sulfasalazine, analytical standard, >=98% (HPLC); BRD-K10670311-001-06-4; BRD-K10670311-001-08-0; BRD-K10670311-001-14-8; BRD-K10670311-001-15-5; Q27166356; Q63398427; F2173-1125; Z1521554012; 2-hydroxy-5-[4-(2-pyridylsulfamoyl)phenyl]azo-benzoic acid; 4-(Pyridyl-2-amidosulfonyl)-3''-carboxy-4''-hydroxyazobenzene; Sulfasalazine, European Pharmacopoeia (EP) Reference Standard; 2-hydroxy-5-[(E)-[4-(2-pyridylsulfamoyl)phenyl]azo]benzoic acid; 5-{4-[(2-pyridylideneamino)sulfonyl]phenyldiazenyl}salicylic acid; Sulfasalazine, United States Pharmacopeia (USP) Reference Standard; 2-hydroxy-5-((4-(N-pyridin-2-ylsulfamoyl)phenyl)diazenyl)benzoic acid; 2-Hydroxy-5-((4-[(2-pyridinylamino)sulfonyl]phenyl)diazenyl)benzoic acid #; 2-Hydroxy-5-({4-[(pyridin-2-yl)sulfamoyl]phenyl}diazenyl)benzoic acid; 2-hydroxy-5-{(E)-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid; 2-HYDROXY-5-((4-((2-PYRIDINYLAMINO)SULFONYL)PHENYL)AZO)BENZOIC ACID [WHO-IP]; 2-hydroxy-5-[(1E)-2-{4-[(pyridin-2-yl)sulfamoyl]phenyl}diazen-1-yl]benzoic acid; 6-oxo-3-(2-[4-(n-pyridin-2-ylsulfamoyl)phenyl]hydrazono)cyclohexa-1,4-dienecarboxylic acid; 6-oxo-3-((4-(pyridin-2-ylsulfamoyl)phenyl) hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid; 6-oxo-3-[[4-(2-pyridinylsulfamoyl)phenyl]hydrazinylidene]-1-cyclohexa-1,4-dienecarboxylic acidSynonyme